NIDAN

Nidan Laboratories And Healthcare Share Price

 

 

Start SIP in NIDAN

Start SIP

Performance

  • Low
  • ₹20
  • High
  • ₹20
  • 52 Week Low
  • ₹16
  • 52 Week High
  • ₹32
  • Open Price₹20
  • Previous Close₹20
  • Volume3,000

Investment Returns

  • Over 1 Month 0%
  • Over 3 Month + 7.59%
  • Over 6 Month -2.46%
  • Over 1 Year -31.9%

Smart Investing Starts Here Start SIP with Nidan Laboratories And Healthcare for Steady Growth!

Invest Now

Nidan Laboratories And Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 14
  • PEG Ratio
  • -
  • Market Cap Cr
  • 28
  • P/B Ratio
  • Average True Range
  • 1.34
  • EPS
  • 1.41
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.39
  • RSI
  • 49.78
  • MFI
  • 68.87

Nidan Laboratories And Healthcare Financials

Nidan Laboratories And Healthcare Technicals

EMA & SMA

Current Price
₹19.85
-0.2 (-1%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹20.30
  • 50 Day
  • ₹19.74
  • 100 Day
  • ₹19.83
  • 200 Day
  • ₹21.36

Resistance and Support

20.37 Pivot Speed
  • R3 21.63
  • R2 21.32
  • R1 20.68
  • S1 19.73
  • S2 19.42
  • S3 18.78

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Nidan Laboratories And Healthcare has an operating revenue of Rs. 61.83 Cr. on a trailing 12-month basis. An annual revenue de-growth of -1% needs improvement, Pre-tax margin of 11% is healthy, ROE of 2% is fair but needs improvement. The company has a reasonable debt to equity of 6%, which signals a healthy balance sheet. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -18% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 66 which is a FAIR score but needs to improve its earnings, a RS Rating of 54 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 27 indicates it belongs to a strong industry group of Medical-Services and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Nidan Laboratories And Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-10 Quarterly Results
2025-07-31 Others To consider other business matters.
2025-05-28 Audited Results
2024-11-14 Quarterly Results
2024-05-23 Audited Results

Nidan Laboratories And Healthcare F&O

Nidan Laboratories And Healthcare Shareholding Pattern

57.04%
40.01%
2.95%

About Nidan Laboratories And Healthcare

  • NSE Symbol
  • NIDAN
  • BSE Symbol
  • ISIN
  • INE0J6L01013

Similar Stocks to Nidan Laboratories And Healthcare

Nidan Laboratories And Healthcare FAQs

Nidan Laboratories And Healthcare share price is ₹19 As on 05 December, 2025 | 13:38

The Market Cap of Nidan Laboratories And Healthcare is ₹27.6 Cr As on 05 December, 2025 | 13:38

The P/E ratio of Nidan Laboratories And Healthcare is 14 As on 05 December, 2025 | 13:38

The PB ratio of Nidan Laboratories And Healthcare is 0.4 As on 05 December, 2025 | 13:38

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23